# | Title | Journal | Year | Citations |
---|
1 | The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Alzheimer's and Dementia | 2011 | 12,681 |
2 | The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Alzheimer's and Dementia | 2011 | 7,498 |
3 | NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease | Alzheimer's and Dementia | 2018 | 5,861 |
4 | Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Alzheimer's and Dementia | 2011 | 5,550 |
5 | The global prevalence of dementia: A systematic review and metaanalysis | Alzheimer's and Dementia | 2013 | 3,654 |
6 | 2016 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2016 | 2,219 |
7 | National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Alzheimer's and Dementia | 2012 | 1,968 |
8 | A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease | Alzheimer's and Dementia | 2014 | 1,863 |
9 | 2020 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2020 | 1,802 |
10 | 2019 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2019 | 1,633 |
11 | 2021 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2021 | 1,622 |
12 | Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Alzheimer's and Dementia | 2011 | 1,547 |
13 | 2018 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2018 | 1,522 |
14 | 2015 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2015 | 1,501 |
15 | Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria | Alzheimer's and Dementia | 2016 | 1,318 |
16 | Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective | Alzheimer's and Dementia | 2015 | 1,187 |
17 | 2013 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2013 | 1,151 |
18 | 2022 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2022 | 1,135 |
19 | Neuroinflammation in Alzheimer's disease: Current evidence and future directions | Alzheimer's and Dementia | 2016 | 1,076 |
20 | 2017 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2017 | 969 |
21 | 2012 Alzheimer's disease facts and figures Alzheimer's Association ∗ | Alzheimer's and Dementia | 2012 | 829 |
22 | Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance | Alzheimer's and Dementia | 2020 | 806 |
23 | The worldwide economic impact of dementia 2010 | Alzheimer's and Dementia | 2013 | 780 |
24 | The worldwide costs of dementia 2015 and comparisons with 2010 | Alzheimer's and Dementia | 2017 | 762 |
25 | Neuropsychiatric symptoms in Alzheimer's disease | Alzheimer's and Dementia | 2011 | 752 |
26 | 2014 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2014 | 750 |
27 | MIND diet associated with reduced incidence of Alzheimer's disease | Alzheimer's and Dementia | 2015 | 665 |
28 | Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study | Alzheimer's and Dementia | 2015 | 656 |
29 | MIND diet slows cognitive decline with aging | Alzheimer's and Dementia | 2015 | 625 |
30 | Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years | Alzheimer's and Dementia | 2019 | 613 |
31 | The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET | Alzheimer's and Dementia | 2015 | 603 |
32 | Defining imaging biomarker cut points for brain aging and Alzheimer's disease | Alzheimer's and Dementia | 2017 | 581 |
33 | 2011 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2011 | 558 |
34 | Inequalities in dementia incidence between six racial and ethnic groups over 14 years | Alzheimer's and Dementia | 2016 | 551 |
35 | The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception | Alzheimer's and Dementia | 2013 | 535 |
36 | [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease | Alzheimer's and Dementia | 2013 | 515 |
37 | Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment | Alzheimer's and Dementia | 2016 | 493 |
38 | 2023 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2023 | 490 |
39 | 2010 Alzheimer's disease facts and figures | Alzheimer's and Dementia | 2010 | 471 |
40 | CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts | Alzheimer's and Dementia | 2018 | 468 |
41 | Understanding the impact of sex and gender in Alzheimer's disease: A call to action | Alzheimer's and Dementia | 2018 | 468 |
42 | The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core | Alzheimer's and Dementia | 2010 | 464 |
43 | Vascular contributions to cognitive impairment and dementia including Alzheimer's disease | Alzheimer's and Dementia | 2015 | 461 |
44 | Vascular dysfunction—The disregarded partner of Alzheimer's disease | Alzheimer's and Dementia | 2019 | 454 |
45 | Core candidate neurochemical and imaging biomarkers of Alzheimer's disease | Alzheimer's and Dementia | 2008 | 447 |
46 | Outcome over seven years of healthy adults with and without subjective cognitive impairment | Alzheimer's and Dementia | 2010 | 447 |
47 | The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans | Alzheimer's and Dementia | 2010 | 443 |
48 | Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association | Alzheimer's and Dementia | 2013 | 443 |
49 | Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive decline | Alzheimer's and Dementia | 2010 | 437 |
50 | Mild cognitive impairment: Disparity of incidence and prevalence estimates | Alzheimer's and Dementia | 2012 | 435 |